PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:03 AM ET

Sponsor Check › Person

KW
No photo found yet (own website and image search run after this page is viewed)

Kenneth E. Weg

Named as an officer, director or promoter on SEC Form D filings · NJ, MA, FL · Nov 15, 2012 → Aug 1, 2013

3deals (issuers)
$247.9Mreported sold
64investors
8Form D filings
2012–2013years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:19 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Kenneth E. Weg is listed as an executive officer and director on 8 SEC Form D filings by 3 issuers between Apr 2009 and Aug 2013: Karyopharm Therapeutics Inc. (Newton, MA — pharmaceuticals — 2013; $165M reported sold to 33 investors), AVEO PHARMACEUTICALS INC (Cambridge, MA — pharmaceuticals — 2009–2011; $60.8M reported sold to 21 investors) and Metamark Genetics, Inc. (Cambridge, MA — biotechnology — 2009–2012; $22.1M reported sold to 10 investors).

What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 4 years. Across those companies the filings report $247.9M sold in total.

Listed alongside Raju Kucherlapati (6 shared filings), Anthony Evnin (3 shared filings), Douglas Cole (3 shared filings), Mansoor Raza Mirza (3 shared filings), Michael Kauffman (3 shared filings) and 25 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Kenneth. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 8 public filings for Kenneth E. Weg and found 7 differences: Kenneth E. Weg's role changed at Metamark Genetics, Inc.: executive officer, director → director; 4 offerings have no amendment in the last 12 months and may still be open; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Kenneth E. Weg has not run yet — it is joining a line of 5,364 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Kenneth E. Weg..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

7 differences found between the filings for Kenneth E. Weg (compared 8 filings on Oct 24, 2026)

Note · Jul 9, 2010 – Nov 15, 2012

Kenneth E. Weg's role changed at Metamark Genetics, Inc.: executive officer, director → director

The Jul 9, 2010 filing lists Kenneth E. Weg as executive officer, director; the Nov 15, 2012 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Jul 9, 2010 ↗Form D · Nov 15, 2012 ↗Kenneth E. Weg — PartnerFacts page ↗Metamark Genetics, Inc. — PartnerFacts page ↗
Sources
Note · Mar 18, 2009 – May 1, 2013

4 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Karyopharm Therapeutics Inc. (latest filing May 1, 2013) · No amendment in the last 12 months on an offering that may still be open — Metamark Genetics, Inc. (latest filing Jul 9, 2010) · No amendment in the last 12 months on an offering that may still be open — Metamark Genetics, Inc. (latest filing May 8, 2009) · No amendment in the last 12 months on an offering that may still be open — AVEO PHARMACEUTICALS INC (latest filing Apr 1, 2009)

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · May 1, 2013 ↗Karyopharm Therapeutics Inc. — PartnerFacts page ↗Form D · Jul 9, 2010 ↗Metamark Genetics, Inc. — PartnerFacts page ↗
Sources
Note · Apr 1, 2009 – May 8, 2009

Kenneth E. Weg is written 2 different ways on the filings

listed as "Kenneth Weg" on 3 filings (from Apr 1, 2009), and "Kenneth E. Weg" on 5 filings (from May 8, 2009).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Apr 1, 2009 ↗Form D · May 8, 2009 ↗Kenneth E. Weg — PartnerFacts page ↗
Sources
Note · Apr 1, 2009 – Nov 3, 2010

Industry group changed between filings — AVEO PHARMACEUTICALS INC

"Other" (Apr 1, 2009); then "Pharmaceuticals" (Nov 3, 2010 to May 31, 2011).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Apr 1, 2009 ↗Form D · Nov 3, 2010 ↗AVEO PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Note · Jul 9, 2010 – Nov 15, 2012

Address moved from Naples, FL to Cambridge, MA — Metamark Genetics, Inc.

The people listed on the Jul 9, 2010 filing give Naples, FL; on the Nov 15, 2012 filing they give Cambridge, MA. The address now on file (245 First Street, Suite 150, Cambridge, MA) is a registered-agent or shared-office address used by 7 issuers.

What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.

Form D · Jul 9, 2010 ↗Form D · Nov 15, 2012 ↗Metamark Genetics, Inc. — PartnerFacts page ↗
Sources
Note · May 8, 2009 – Jul 9, 2010

Address moved from Princeton, NJ to Naples, FL — Metamark Genetics, Inc.

The people listed on the May 8, 2009 filing give Princeton, NJ; on the Jul 9, 2010 filing they give Naples, FL. The address now on file (245 First Street, Suite 150, Cambridge, MA) is a registered-agent or shared-office address used by 7 issuers.

What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.

Form D · May 8, 2009 ↗Form D · Jul 9, 2010 ↗Metamark Genetics, Inc. — PartnerFacts page ↗
Sources
Note · Apr 1, 2009 – Aug 1, 2013

Kenneth E. Weg is listed with 3 different address states: MA, NJ, FL

MA on 6 filings (Apr 1, 2009 to Aug 1, 2013); NJ on 1 filing (May 8, 2009); FL on 1 filing (Jul 9, 2010).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Apr 1, 2009 ↗Form D · May 8, 2009 ↗Form D · Jul 9, 2010 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 8 offerings reports sales commissions totalling $3,645,000; 0 report finder's fees; 0 report proceeds to related persons.

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Aug 1, 2013 D
Karyopharm Therapeutics Inc.
File 021-200576
$0$0$0None listed on this filingEDGAR ↗
May 1, 2013 D
Karyopharm Therapeutics Inc.
File 021-195853
$0$0$0None listed on this filingEDGAR ↗
Nov 15, 2012 D
Metamark Genetics, Inc.
File 021-187034
$0$0$0None listed on this filingEDGAR ↗
May 31, 2011 D
AVEO PHARMACEUTICALS INC
File 021-160532
$0$0$0None listed on this filingEDGAR ↗
Nov 3, 2010 D
AVEO PHARMACEUTICALS INC
File 021-149990
$3,645,000$0$0J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗
Canaccord Genuity Inc. BrokerCheck CRD 1020 ↗
RBC Capital Markets Corporation BrokerCheck CRD 31194 ↗		EDGAR ↗
Jul 9, 2010 D
Metamark Genetics, Inc.
File 021-144637
$0$0$0None listed on this filingEDGAR ↗
May 8, 2009 D
Metamark Genetics, Inc.
File 021-130791
$0$0$0None listed on this filingEDGAR ↗
Apr 1, 2009 D
AVEO PHARMACEUTICALS INC
File 021-76653
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 3

Every issuer that named Kenneth E. Weg on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

KT
Pharmaceuticals

Karyopharm Therapeutics Inc.

Newton, MA · May 1, 2013 → Aug 1, 2013 · 2 filings
  • Aug 1, 2013 · D · $18,999,996 sold of $18,999,996 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 1, 2013 · D · $20,500,000 sold of $60,000,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $165M from 33 investors (100% of the $19M target) as of the latest filing. Kenneth is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

MG
Biotechnology

Metamark Genetics, Inc.

Cambridge, MA · May 8, 2009 → Nov 15, 2012 · 3 filings
  • Nov 15, 2012 · D · $9,109,287 sold of $9,109,287 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 9, 2010 · D · $22,102,753 sold of $42,102,753 · 3 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • May 8, 2009 · D · $2,650,000 sold of $10,500,000 · 6 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $22.1M from 10 investors (100% of the $9.11M target) as of the latest filing. Kenneth is listed as director, executive officer on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

AP
Pharmaceuticals

AVEO PHARMACEUTICALS INC

Cambridge, MA · Apr 1, 2009 → May 31, 2011 · 3 filings
  • May 31, 2011 · D · $7,499,997 sold of $7,499,997 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 3, 2010 · D · $60,750,000 sold of $60,750,000 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 1, 2009 · D · $30,000,000 sold of $60,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $60.8M from 21 investors (100% of the $7.5M target) as of the latest filing. Kenneth is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Kenneth 30

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

RK
No photo found yet (own website and image search run after this page is viewed)
Person

Raju Kucherlapati

Director · 6 shared filings (2 issuers) · also on 4 other issuers

Raju Kucherlapati is on 6 issuers in total — a repeat sponsor. Their page lists every one.

NG
No photo found yet (own website and image search run after this page is viewed)
Person

Nicholas Galakatos

Director · 3 shared filings (1 issuer) · also on 31 other issuers

Nicholas Galakatos is on 32 issuers in total — a repeat sponsor. Their page lists every one.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Russell Hirsch

Director · 3 shared filings (1 issuer) · also on 11 other issuers

Russell Hirsch is on 12 issuers in total — a repeat sponsor. Their page lists every one.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

Douglas Cole

Director · 3 shared filings (1 issuer) · also on 8 other issuers

Douglas Cole is on 9 issuers in total — a repeat sponsor. Their page lists every one.

AE
No photo found yet (own website and image search run after this page is viewed)
Person

Anthony Evnin

Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

Ronald DePinho

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

TN
No photo found yet (own website and image search run after this page is viewed)
Person

Tuan Ha-Ngoc

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

MK
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Kauffman

Director, Executive Officer · 3 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Mansoor Raza Mirza

Director · 3 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

LC
No photo found yet (own website and image search run after this page is viewed)
Person

Lynda Chin

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Sharon Shacham

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

DJ
No photo found yet (own website and image search run after this page is viewed)
Person

David Johnston

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

RY
No photo found yet (own website and image search run after this page is viewed)
Person

Robert C. Young

Director · 2 shared filings (1 issuer)

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

KB
No photo found yet (own website and image search run after this page is viewed)
Person

Kenneth Bate

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

WS
No photo found yet (own website and image search run after this page is viewed)
Person

William Slichenmyer

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

Jeno Gyuris

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

NS
No photo found yet (own website and image search run after this page is viewed)
Person

Norman C. Selby

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

David Cordo

Executive Officer · 2 shared filings (1 issuer) · also on 7 other issuers

David Cordo is on 8 issuers in total — a repeat sponsor. Their page lists every one.

BG
No photo found yet (own website and image search run after this page is viewed)
Person

Barry Greene

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

EE
No photo found yet (own website and image search run after this page is viewed)
Person

Elan Ezickson

Executive Officer · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

DJ
No photo found yet (own website and image search run after this page is viewed)
Person

David Johnson

Executive Officer · 1 shared filing (1 issuer) · also on 16 other issuers

David Johnson is on 17 issuers in total — a repeat sponsor. Their page lists every one.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Higgins

Director · 1 shared filing (1 issuer) · also on 10 other issuers

Robert Higgins is on 11 issuers in total — a repeat sponsor. Their page lists every one.

JV
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Vittiglio

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

KB
No photo found yet (own website and image search run after this page is viewed)
Person

Ken Bate

Director · 1 shared filing (1 issuer)

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Bailey

Executive Officer · 1 shared filing (1 issuer) · also on 4 other issuers

Michael Bailey is on 5 issuers in total — a repeat sponsor. Their page lists every one.

PB
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Brannelly

Executive Officer · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

GC
No photo found yet (own website and image search run after this page is viewed)
Person

Gregory C. Critchfield

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

AB
No photo found yet (own website and image search run after this page is viewed)
Person

Alan Barber

Executive Officer · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

HT
No photo found yet (own website and image search run after this page is viewed)
Person

Henri A. Termeer

Director · 1 shared filing (1 issuer)

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

DP
No photo found yet (own website and image search run after this page is viewed)
Person

Deepika R. Pakianathan

Director · 1 shared filing (1 issuer)

Listed on the same filings as Kenneth E. Weg. Their page shows their other deals.

The team behind the deals

Registrations and other filings

Adviser registration (Form ADV)

None of the 3 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Kenneth E. Weg by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 3 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Kenneth E. Weg is listed on: none on file. No website or social profile named in AVEO PHARMACEUTICALS INC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #352,398 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Cambridge, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗New Jersey state courts — find the court ↗Massachusetts MassCourts ↗Hillsborough County FL Clerk (HOVER) ↗Miami-Dade Clerk online case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

New Jersey Secretary of State business search ↗Massachusetts Secretary of State business search ↗Florida Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Kenneth E. Weg appears on a new Form D, or when a court case or SEC action is matched to them. See plans →